Advertisement

Gastroenterology

Home Gastroenterology
The American Cancer Society has set a goal of a 40 percent reduction in overall cancer mortality by 2035

ACS Sets Goal to Cut Cancer Mortality 40 Percent by 2035

Goal based on decrease in overall cancer death rates at pace seen among college graduates
In 2018

2018 Saw More Employed Physicians Than Self-Employed

Proportion of physicians working in practices wholly owned by physicians dropped to 54 percent in 2018
A new test can predict the course of inflammatory bowel disease in patients

Biomarker Test Predicts Mild, Serious IBD in Newly Diagnosed

Test based on genetic signature of CD8 T cells during active disease
In 2018

CDC: Uninsurance Levels Did Not Change Significantly in 2018

Uninsurance increased among adults aged 45 to 64 years; increase seen in high-deductible health plans
For patients with hepatocellular carcinoma

Percutaneous Ablation in Liver Cancer Tied to Better Outcomes

Intervention linked to better short-term outcomes versus surgical procedures
Global goals for reducing alcohol use are unlikely to be achieved

Alcohol Consumption Per Capita Increasing Among Adults

By 2030, prevalence of current drinking set to increase to 50 percent
In 2015 to 2016

In 2015 to 2016, 45.8 Percent of U.S. Population Used Rx Drugs

Prescription drug use increased with age, reaching 85.0 percent for those aged 60 years and older
In response to public demands for action to control drug costs

Prices Will Soon Be Included in TV Drug Ads

Regulations will require companies to disclose prices of meds costing more than $35 for a month's supply
Low body mass index among men entering adult life is associated with an increased incidence of Crohn disease and ulcerative colitis up to 40 years later

In Men, Low BMI Tied to Later Inflammatory Bowel Disease

Risk lasts through 40 years of adulthood for underweight adolescent men
The average price for single-source brand-name drugs is higher in the United States than in other countries

External Reference Pricing Could Cut Drug Costs in U.S.

Prices averaged 3.2 to 4.1 times higher in U.S.; differential varied from 1.3 to 70.1 for individual drugs